GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Early Breast Cancer
Interventions: DRUG: monosialic gangliosides|OTHER: Placebo
Sponsor: Henan Cancer Hospital